Navigation Links
NYU Langone Medical Center receives $5.4 million NYSTEM grant for stem cell research
Date:6/21/2010

NEW YORK, NY June 21, 2010 NYU Langone Medical Center has received a $5.4 million shared facility award from the Empire State Stem Cell Boards New York State Stem Cell Science (NYSTEM) program. The grant will be used to expand the NYU RNAi Core Facility and build shared access to the shRNA Core at Mount Sinai School of Medicine. The purpose of the collaboration is to provide stem cell researchers in New York State with a truly comprehensive, state-of-the-art facility to conduct high-throughput screening (HTS) to investigate gene function in cell based assays. The NYU RNAi Core Facility utilizes RNA interference (RNAi), an invaluable tool in the identification of new therapeutic targets, as well as novel methods for treatment of disease.

We are truly honored to receive this award in recognition of the unique stem cell research being done at NYU Langone Medical Center, said Vivian S. Lee, MD, PhD, MBA, vice dean for science and chief scientific officer & senior vice president at NYU Langone Medical Center. The NYU RNAi Core Facility demonstrates the Medical Centers commitment to cutting edge technologies to advance scientific discovery and change the landscape of health care.

The NYU RNAi Core Facility was established in June 2008 with generous support from the Helen L. and Martin S. Kimmel Center for Stem Cell Biology and the NYU Cancer Institute. Screens performed at the NYU RNAi screening facility aim to identify new therapeutic targets for the generation of cancer-stem cell-specific therapies. The facility also actively promotes an open-access policy in which it promotes the sharing of primary data to the scientific community by making the data generated from RNAi screens publicly available post-publication.

The NYU RNAi Core Facility is led by Ramanuj DasGupta, PhD, assistant professor in the Department of Pharmacology and research faculty at the NYU Cancer Institute and the Helen L. and Martin S. Kimmel Center for Stem Cell Biology at the Skirball Institute of Biomolecular Medicine. The facility is managed by Dr. Chi Yun, PhD, who serves as the assistant director of the NYU RNAi Core. Dr. DasGupta is working with co-principal investigator, Ihor Lemischka, PhD, professor of Gene and Cell Medicine and Developmental and Regenerative Biology at Mount Sinai School of Medicine.

This multi-institutional grant will serve the entire academic community in the New York State and will provide a comprehensive set of cutting edge technologies to researchers working in stem cell-related research, said Ruth Lehmann, PhD, Director of the Center and of the Skirball Institute, the Laura and Isaac Perlmutter Chair, and a Howard Hughes investigator. The funding provided by NYSTEM for the creation of this shared facility with molecular tools such as RNAi-based HTS will prove invaluable for the identification of new therapeutic targets.

The NYSTEM grant for shared facilities for stem cell research supports the establishment and operation of multi-institutional core research facilities to maximize the expertise, efficiency and quality of stem cell research in New York State. The grant is multi-institutional, serving the entire academic community in the New York State to promote a unique opportunity for fostering collaborations between different labs working with stem cells or conducting stem cell-related research. Covering up to four years, the grant will fund specialized resources and facilities to be operated on a shared-use basis in support of basic, applied, translational, pre-clinical or clinical stem cell-related research. Seven shared facility awards totaling more than $27 million were given out in the latest funding round.


'/>"/>

Contact: Lisa Greiner
lisa.greiner@nyumc.org
212-404-3532
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Related biology news :

1. NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008
2. NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis
3. NYU Langone Medical Center awarded NIH grants totaling $1,560,000
4. American College of Medical Genetics responds to new FDA labeling decision for warfarin
5. M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution
6. Boston University biomedical engineers find chink in bacterias armor
7. $22 million gift from Alfred Taubman launches new biomedical research institute
8. USC biomedical team to participate in $6 million low vision project
9. 3 Columbia University Medical Center faculty elected to Institute of Medicine
10. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
11. UMass Medical School researchers receive $8.5M grant award to fight AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... --  Veridium , a leader in biometrics-based authentication ... James Stickland . Stickland, a seasoned financial ... served in senior executive roles for HSBC, JPMorgan ... a pipeline of venture capital and accelerating innovation ... as managing director of U.K.-based fintech firm Red ...
(Date:12/2/2016)... 1, 2016 The report "Biometric ... Future Technology (Iris Recognition System), Vehicle Type (Passenger ... Forecast to 2021", published by MarketsandMarkets, the market ... 2016, and is projected to grow to USD ... 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... , Nov. 29, 2016   Neurotechnology ... and object recognition technologies, today released FingerCell ... fingerprint recognition solutions that run on low-power, ... template using less than 128KB of memory, ... devices that have limited on-board resources, such ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... commercializing products to treat rare diseases where there is ... be hosting an Investor Webcast Event Friday, December 16, ... innate defense regulators (IDRs) as a new drug class, ... the recently announced and published Phase 2 clinical data ...
(Date:12/8/2016)... Dec. 8, 2016 Savannah River Remediation ... and selected NewTechBio,s NT-MAX Lake & Pond ... beneficial bacteria, in conjunction with Hexa Armor/ Rhombo ... with National Pollutant Discharge Elimination System requirements. ... a steady history of elevated pH levels, above ...
(Date:12/8/2016)... to fuel Philadelphia,s innovative digital ... Southeastern Pennsylvania (" Ben Franklin "); Independence ... Cross; and Safeguard Scientifics ("Safeguard") (NYSE: SFE ... funding initiative over a four year period to grow ... burgeoning economic vitality in digital health, Ben Franklin ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. ... and expansion clinical trial for its lead drug candidate, AC0010, at the World ... trial was to determine the safety, antitumor activity, and recommended phase II dosage ...
Breaking Biology Technology: